Dopaminergic drugs and the risk of hip or femur fracture:a population-based case-control study
SUMMARY: The effect of dopaminergic medication on the risk of hip/femur fractures is not clear. Our results showed a nearly twofold increased risk of hip/femur fractures in current dopaminergic drug users. Concomitant use of antidepressants further increased this risk. Fracture risk assessment may be warranted in elderly users of dopaminergic drugs. INTRODUCTION: Dopaminergic drugs, often used in the treatment of Parkinson's disease, have several pharmacological effects that may increase or decrease the risk of falling and fractures. Thus, the effect of dopaminergic medication on the risk of h... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2011 |
Reihe/Periodikum: | Arbouw , M E L , Movig , K L L , van Staa , T P , Egberts , A C G , Souverein , P C & de Vries , F 2011 , ' Dopaminergic drugs and the risk of hip or femur fracture : a population-based case-control study ' , Osteoporosis International , vol. 22 , no. 7 , pp. 2197-204 . https://doi.org/10.1007/s00198-010-1455-3 |
Schlagwörter: | Adolescent / Adult / Aged / Antidepressive Agents/adverse effects / Case-Control Studies / Dopamine Agents/administration & dosage / Female / Femoral Fractures/chemically induced / Follow-Up Studies / Hip Fractures/chemically induced / Humans / Male / Middle Aged / Netherlands/epidemiology / Psychotropic Drugs/adverse effects / Risk Factors / Young Adult |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26822261 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://cris.maastrichtuniversity.nl/en/publications/efc090c6-4da3-4742-a12f-4ac9381c81a9 |